Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Breast 1

Conditions

Smoking Cessation 1Smoking 1Neoplasms 1Lung Neoplasms 1Breast Neoplasms 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Nicotine × 1 year × Clear all
NCT05535192 2026-04-23

THRIVE-65

Dana-Farber Cancer Institute

Phase NA Recruiting
270 enrolled
Breast

Breast Neoplasms

NCT06218823 2025-10-27

Tobacco Treatment Comparison for Cancer Care

University of Wisconsin, Madison

Phase 4 Completed
52 enrolled 9 charts

Neoplasms, Smoking Cessation

NCT04200534 2025-08-22

Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Active not recruiting
358 enrolled
Thoracic

Lung Neoplasms, Smoking

Data powered by HemOnc (CC BY 4.0) Colophon âš¡